Our extensive experience in health technology assessment (HTA) through providing strategic advice and guiding evidence generation to support submissions to UK HTA bodies, enables us to provide you with a tailored solution to reimbursement and patient access.
Economic Evidence for Envarsus® Kidney Transplant Recipients: A Targeted Literature Review to Support UK Cost-Effectiveness Modelling.